Spruce Biosciences, Inc.
SPRB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $39 | $96 | $24 | $43 |
| Short-Term Investments | $0 | $0 | $55 | $46 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $6 | $5 | $3 |
| Total Curr. Assets | $44 | $102 | $84 | $92 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | -$55 | $32 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $55 | $1 |
| Total NC Assets | $1 | $2 | $2 | $35 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $45 | $104 | $86 | $126 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $1 | $3 |
| Short-Term Debt | $2 | $2 | $2 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $5 | $0 | $0 |
| Other Curr. Liab. | $12 | $14 | $9 | $6 |
| Total Curr. Liab. | $15 | $24 | $12 | $9 |
| LT Debt | $1 | $3 | $5 | $6 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $3 | $5 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $2 |
| Total Liabilities | $16 | $27 | $17 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$250 | -$197 | -$149 | -$103 |
| AOCI | $0 | $0 | -$1 | -$0 |
| Other Equity | $279 | $274 | $218 | $215 |
| Total Equity | $29 | $77 | $68 | $111 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $45 | $104 | $86 | $126 |
| Net Debt | -$36 | -$92 | -$18 | -$36 |